TEST BANK k
RAU’s kRespiratory kCare kPharmacology
9TH EDITION
k
BY kGARDENHIRE
TEST BANK k
,Description
Test kBank kfor kRau’s kRespiratory kCare kPharmacology k9th kEdition kGardenhire
Test kBank kfor kRau’s kRespiratory kCare kPharmacology, k9th kEdition, kGardenhire,
kISBN-10:k0323299687, kISBN-13: k9780323299688
Table kof kContents
Unit kI: kBasic kConcepts kand kPrinciples kin kPharmacology
1. kIntroduction kto kRespiratory kCare kPharmacology
2. kPrinciples kof kDrug kAction
3. kAdministration kof kAerosolized kAgents
4. kCalculating kDrug kDoses
5. kThe kCentral kand kPeripheral kNervous kSystems
Unit kII: kDrugs kUsed kto kTreat kthe kRespiratory kSystem
6. kAdrenergic k(Sympathomimetic) kBronchodilators
7. kAnticholinergic k(Parasympatholytic) kBronchodilators
8. kXanthines
9. kMucus-Controlling kDrug kTherapy
10. kSurfactant kAgents
11. kCorticosteriods k in kRespiratory kCare
12. kNonsteroidal kAntiasthma kAgents
13. kAerosolized kAntiinfective kAgents
14. kAntimicrobial kAgents
15. kCold kand kCough kAgents
16. kSelected kAgents kof kPulmonary kValue
17. kNeonatal kand kPediatric kAerosolized kDrug kTherapy
Unit kIII: kCritical kCare, kCardiovascular, kand kPolysomnography kAgents
18. kSkeletal kMuscle kRelaxants k(Neuromuscular kBlocking kAgents)
19. kDiuretic kAgents
20. kDrugs kAffecting kthe kCentral kNervous kSystem
21. kVasopressors, kInotropes, kand kAntiarrythmic kAgents
22. kDrugs kAffecting kCirculation: kAntihypertensives, kAntianginals, k Antithrombotics
23. kSleep kand kSleep kPharmacology
,Chapter k01: kIntroduction kto kRespiratory kCare kPharmacology
Gardenhire: kRau’s kRespiratory kCare kPharmacology, k9th kEdition
k
MULTIPLE kCHOICE
1. What kis kthe kname kof kthe kreceptor ksites kthat kare klocated kin kthe kperipheral kvasculature, kthe
kheart, kbronchialkmuscle, kand kbronchial kblood kvessels?
a. Beta k2 kreceptors c. Alpha kreceptors
b. Gamma kreceptors d. k k k Beta k1 kreceptors
ANS: k C
Alpha kreceptors kare klocated kin kthe kperipheral kvasculature, kthe kheart, kbronchial kmuscle, kand
kbronchialkblood kvessels.
PTS: k 1
2. Which kreceptor ksite kresults kin ktachycardia, kan kincreased kpotential kfor karrhythmias, kand kan
kincreasedkcardiac koutput?
a. Beta k1 kreceptor c. Alpha kreceptor
b. Beta k2 kreceptor d. k Delta kreceptor
ANS: k A
Stimulation k of kthe k beta-1 kreceptors kresults kin ktachycardia, kan kincreased kpotential kfor
karrhythmias, kandkan kincreased kcardiac koutput. kIn kadministering kdrugs kto kthe kpulmonary
ksystem, kstimulation kof kthe kbeta-1ksites k is knot k desired. kHowever, k most krespiratory
kpharmacologic kagents k have ksome kbeta-1 kstimulatory k effect.
PTS: k 1
3. Stimulation kof kthe kbeta k2 kreceptors kcauses k k
a. peripheral kvasoconstriction kand kmild kbronchoconstriction kin kthe klungs.
b. tachycardia, kan kincreased kpotential kfor karrhythmias, kand kan kincreased kcardiac koutput.
c. bronchodilation.
d. peripheral kvasodilation, kbradycardia, kand kdecreased kcardiac koutput.
ANS: k C
Stimulation kof kthe kbeta-2 kreceptors kin kthe klungs kcauses kbronchodilation.
PTS: k 1
4. Acetylcholine kstimulates k k
a. the kVagus knerve.
b. the kadrenergic kreceptors.
c. the ksympathetic knervous ksystem.
d. the kcholinergic kreceptors.
ANS: k D
Acetylcholine kstimulates kthe kcholinergic kreceptors.
PTS: k 1
5. What kimmunoglobulin kantibody ksensitizes kthe k mast kcell?
a. Leukotrienes c. Histamine
, b. IgE d. k Prostaglandins
ANS: k B
The kIgE k(reagin) kantibodies ksensitize kthe kmast kcell. kRepeated kexposure kto kthe kantigen
kcauses kthekdegranulation kof kthe k mast kcell.
PTS: k 1
6. Which kof kthe kfollowing kis kcaused kby khistamine krelease kfrom kthe kmast kcells?
I. Bronchodilation
II. Increased kbronchial kgland ksecretion
III. Increased kamount kof kmucus kpresent kin kthe kairways
a. I kand kII k only c. III konly
b. II kand kIII konly d. k k k I, kII, kIII
ANS: k B
Histamine kis kalso ka kpotent kbronchoconstrictor. kIn kaddition kto kits kbronchoconstrictive kactivity,
khistamine
II) kincreases kbronchial kgland ksecretion, kcausing kIII) kan kincrease kin kthe kamount kof
kmucus kpresentkin kthe kairways. kHistamine k may kalso k have kan k effect k on kvascular
kpermeability ksimilar kto kthe k effect kof- kSRS-A.
PTS: k 1
7. A ksympathomimetic kdrug kwould kcause k k
a. bronchodilation. c. Histamine krelease.
b. bronchoconstriction. d. k Vagus knerve kstimulation.
ANS: k A
A ksympathomimetic kdrug kwould kcause kbronchodilation. kSympathomimetic kagents kare kthe kdrugs kmost
kcommonly kused kto kreverse kbronchospasm.
PTS: k 1
8. Stimulation kof kthe ksympathetic k nervous ksystem kcauses k k
a. vascular kpermeability. c. bronchodilation.
b. decreased kblood kpressure. d. k bronchoconstriction.
ANS: k C
Sympathetic knervous ksystem kstimulation kcauses kbronchodilation.
PTS: k 1
9. Which kof kthe kfollowing kwould kNOT kcause ka kbronchospasm kor kbronchoconstriction?
a. Leukotrienes c. Histamine
b. Beta k1 kreceptors d. k Prostaglandins
ANS: k B
Beta-1 kreceptors kwould knot kcause ka kbronchospasm kor kbronchoconstriction. kLeukotrienes
kare kone kofkmany kchemical k mediators kreleased kby kthe k mast kcells. kLeukotrienes kcause ka kdirect,
kstrong kbronchoconstriction. kHistamine k is kalso ka kpotent kbronchoconstrictor. kProstaglandins
kcause ka kstrong kbronchospasm, k especially kin kasthmatic kpatients.
PTS: k 1